Up-regulation of murine double minute clone 2 (MDM2) gene expression in rat brain after morphine, heroin, and cocaine administrations

Neuroscience Letters

Volumn 352, Issue 3, 2003, Pages 216-220

  Jiang, Yan ^a   Yang, Weilin ^a   Zhou, Yuqing ^a   Ma, Lan ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Cocaine; Drug addiction; Gene expression; Heroin; Morphine; Murine double minute clone 2

Indexed keywords

COCAINE; DIAMORPHINE; MESSENGER RNA; MORPHINE; ONCOPROTEIN; PROTEIN P53;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN CORTEX; CLONE; CONTROLLED STUDY; DRUG DEPENDENCE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE LOCATION; HIPPOCAMPUS; HISTOCHEMISTRY; IN SITU HYBRIDIZATION; LOCUS CERULEUS; MALE; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; THALAMUS; UPREGULATION;

ANIMALS; BRAIN; COCAINE; HEROIN; MALE; MICE; MORPHINE; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; RATS; RATS, SPRAGUE-DAWLEY; UP-REGULATION;

EID: 1642417380     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2003.08.053     Document Type: Article

References (25)

1. Barak Y., Gottlieb E., Juven-Gershon T., Oren M. Regulation of MDM2 expression by p53: alternative promoters produce transcripts with non-identical translation potential. Genes Dev. 8:1994;1739-1749.
2. Bates S., Vousden K.H. Mechanisms of p53-mediated apoptosis. Cell. Mol. Life Sci. 55:1999;28-37.
3. Bohn L.M., Gainetdinov R.R., Lin F.T., Lefkowitz R.J., Caron M.G. Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence. Nature. 408:2000;720-723.
4. de Oca Luna R.M., Tabor A.D., Eberspaecher H., Hulboy D.L., Worth L.L., Colman M.S., Finlay C.A., Lozano G. The organization and expression of the MDM2 gene. Genomics. 33:1996;352-357.
5. Fan X.L., Zhang J.S., Zhang X.Q., Yue W., Ma L. Differential regulation of beta-arrestin 1 and beta-arrestin 2 gene expression in rat brain by morphine. Neuroscience. 117:2003;383-389.
6. Goswami R., Dawson S.A., Dawson G., Cyclic A.M.P. protects against staurosporine and wortmannin-induced apoptosis and opioid-enhanced apoptosis in both embryonic and immortalized (F-11kappa7) neurons. J. Neurochem. 70:1998;1376-1382.
7. Haupt Y., Maya R., Kazaz A., Oren M. MDM2 promotes the rapid degradation of p53. Nature. 387:1997;296-299.
8. Honda R., Tanaka H., Yasuda H. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 420:1997;25-27.
9. Jones S.N., Roe A.E., Donehower L.A., Bradley A. Rescue of embryonic lethality in MDM2-deficient mice by absence of p53. Nature. 378:1995;206-208.
10. Kubbutat M.H., Jones S.N., Vousden K.H. Regulation of p53 stability by MDM2. Nature. 387:1997;299-303.
11. Landry M., Roche D., Angelova E., Calas A. Expression of galanin in hypothalamic magnocellular neurones of lactating rats: co-existence with vasopressin and oxytocin. J. Endocrinol. 155:1997;467-481.
12. Leshner A.I. Addiction is a brain disease, and it matters. Science. 278:1997;45-47.
13. Mao J., Sung B., Ji R.R., Lim G. Neuronal apoptosis associated with morphine tolerance: evidence for an opioid-induced neurotoxic mechanism. J. Neurosci. 22:2002;7650-7661.
14. Momand J., Zambetti G.P. Mdm-2: 'big brother' of p53. J. Cell. Biochem. 64:1997;343-352.
15. Montes de Oca Luna R., Wagner D.S., Lozano G. Rescue of early embryonic lethality in MDM2-deficient mice by deletion of p53. Nature. 378:1995;203-206.
16. Nassogne M.C., Louahed J., Evrard P., Courtoy P.J. Cocaine induces apoptosis in cortical neurons of fetal mice. J. Neurochem. 68:1997;2442-2450.
17. Nestler E.J., Aghajanian G.K. Molecular and cellular basis of addiction. Science. 278:1997;58-63.
18. Oliveira M.T., Rego A.C., Morgadinho M.T., Macedo T.R., Oliveira C.R. Toxic effects of opioid and stimulant drugs on undifferentiated PC12 cells. Ann. N. Y. Acad. Sci. 965:2002;487-496.
19. Price B.D., Park S.J. DNA damage increases the levels of MDM2 messenger RNA in wtp53 human cells. Cancer Res. 54:1994;896-899.
20. Shenoy S.K., McDonald P.H., Kohout T.A., Lefkowitz R.J. Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin. Science. 294:2001;1307-1313.
21. Strous G.H., Schantl J.A. β-Arrestin and MDM2, unsuspected partners in signaling from the cell surface. Science STKE. 110:2001;PE41.
22. Tu Y., Hou S.T., Huang Z., Robertson G.S., MacManus J.P. Increased MDM2 expression in rat brain after transient middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 18:1998;658-669.
23. Wang P., Gao H., Ni Y.X., Wang B., Wu Y., Ji L., Qin L., Ma L., Pei G. Beta-arrestin 2 functions as a G-protein-coupled receptor-activated regulator of oncoprotein MDM2. J. Biol. Chem. 278:2003;6363-6370.
24. Whistler J.L., von Zastrow M. Morphine-activated opioid receptors elude desensitization by beta-arrestin. Proc. Natl. Acad. Sci. USA. 95:1998;9914-9919.
25. Woods D.B., Vousden K.H. Regulation of p53 function. Exp. Cell Res. 264:2001;56-66.